neurological disorders | GenomeWeb

neurological disorders

Metagenomic sequencing may be a good tool to improve the diagnostic rate because it is such a broad approach and does not require "guessing" at the potential pathogen. 

Researchers identified Neanderthal alleles associated with human conditions using genotypic and phenotypic information in health records for more than 28,000 individuals. 

The results showed that syndromic forms of autism are more likely when children have alterations of genes in the mGluR pathway.

The life sciences company can now offer its genetic tests in all 50 states in the US, as well as Canada and several other countries. 

TwoXar will use the funds to expand its engineering and commercial teams and  support partnerships focused on drug candidates for metabolic and neurological diseases.

The company's platform offers space and computational tools for exploring, sharing, and storing genomic data in the context of genetic disorders.

Amarantus will use the investment to develop and commercialize its neurology diagnostic products and drug candidates, and for other working capital expenses. 

The test, called Neurome, is available from Athena, Quest Diagnostics' genetic testing business for neurological disorders, and is performed by Personalis.

Researchers also plan to launch a prospective randomized clinical trial to test the effectiveness of whole-genome sequencing compared to the standard of care.

NEW YORK (GenomeWeb News) – The Translational Genomics Research Institute held a ribbon-cutting today to launch a new clinic within the Center for Rare Childhood Disorders that will focus on using genomic and molecular techniques to diagnose and treat such disorders.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.